Nellie Katsou

Pharmathen Holding 2 Ltd. is an investment holding British company founded in 2015. The private company is based in St. Helier, UK. The company's main function is to hold investments.

Part of Pharmathen Holding 4 Ltd., Pharmathen Global Ltd. provides management services. The company is based in Hertford, UK.

Pharmathen Holding 1 Ltd. provides investment services. The private company is based in Saint Helier, UK.

Pharmathen Holding 4 Ltd. is a holding British company that operates through its subsidiaries in the pharmaceutical industry. The private company is involved in the development and marketing of pharmaceutical products.

Pharmathen Holding 3 Ltd. is a British investment company founded in 2015. The private company is based in Saint Helier, UK. The company provides investment services.

Part of Pharmathen Holding 4 Ltd., Pharmathen Global Ltd. provides management services. The company is based in Hertford, UK.

Pharmathen Holding 4 Ltd. is a holding British company that operates through its subsidiaries in the pharmaceutical industry. The private company is involved in the development and marketing of pharmaceutical products.

Pharmathen Holding 1 Ltd. provides investment services. The private company is based in Saint Helier, UK.

Pharmathen Holding 3 Ltd. is a British investment company founded in 2015. The private company is based in Saint Helier, UK. The company provides investment services.

Pharmathen Holding 2 Ltd. is an investment holding British company founded in 2015. The private company is based in St. Helier, UK. The company's main function is to hold investments.

Pharmathen Holding 3 Ltd. is a British investment company founded in 2015. The private company is based in Saint Helier, UK. The company provides investment services.

Pharmathen Holding 4 Ltd. is a holding British company that operates through its subsidiaries in the pharmaceutical industry. The private company is involved in the development and marketing of pharmaceutical products.

Part of Pharmathen Holding 4 Ltd., Pharmathen Global Ltd. provides management services. The company is based in Hertford, UK.

Pharmathen Holding 1 Ltd. provides investment services. The private company is based in Saint Helier, UK.

Part of Pharmathen Holding 4 Ltd., Pharmathen Global Ltd. provides management services. The company is based in Hertford, UK.

Pharmathen Holding 3 Ltd. is a British investment company founded in 2015. The private company is based in Saint Helier, UK. The company provides investment services.

Pharmathen Holding 1 Ltd. provides investment services. The private company is based in Saint Helier, UK.

Pharmathen Holding 2 Ltd. is an investment holding British company founded in 2015. The private company is based in St. Helier, UK. The company's main function is to hold investments.

Pharmathen SA develops, manufactures, and markets pharmaceuticals. Its products include a-cnotren, adicanil, alcinin, atostana, aurid, azapin, belifax, calci-10, deprevix cr, esmocard, farbovil, faxiven, depilonine pro, depilonine cream, aripiprazole, atorvastatin, brinzolamide, caspofungin, and clopidogrel. The company was founded in 1969 and is headquartered in Pallini, Greece.

Pharmathen Pharmaceuticals SA develops and markets health care products. It manufactures cosmetics and pharmaceutical products and licenses out to the pharmaceutical companies in Europe, Canada, Australia, South Africa and the United States. The firm also distributes products in Africa, Asia, Latin America and the Middle East through a network of agents and distributors. The company was founded by Nicolas Katsos in 1969 and is headquartered in Pallini, Greece.

Algae Farms SA engages in the production of renewable and conventional biofuels. Its products include algae pellets and briquettes, and bio-algae. The company was founded by Panagiotis Panagiotopoulos in February 20, 2014 and is headquartered in Preveza, Greece.

Algae Farms SA engages in the production of renewable and conventional biofuels. Its products include algae pellets and briquettes, and bio-algae. The company was founded by Panagiotis Panagiotopoulos in February 20, 2014 and is headquartered in Preveza, Greece.

Algae Farms SA engages in the production of renewable and conventional biofuels. Its products include algae pellets and briquettes, and bio-algae. The company was founded by Panagiotis Panagiotopoulos in February 20, 2014 and is headquartered in Preveza, Greece.

Pharmathen was founded in 1969 in Athens, as a private pharmaceutical company, and is focused on the development and marketing of pharmaceuticals, with a strong position in generics. With 3 state of the art research laboratories and 2 manufacturing units, Pharmathen is a completely vertically integrated company and its activities extend from the development of pharmaceutical products up to their distribution. The company's human resources works in the sectors of Research & Development (R&D), production and distribution of drugs to different countries worldwide. Now, Pharmathen's products are approved in all EU markets and distribution rights have been granted to the largest pharmaceutical companies in the world, particularly in Europe, the United States of America and Canada.

Pharmathen was founded in 1969 in Athens, as a private pharmaceutical company, and is focused on the development and marketing of pharmaceuticals, with a strong position in generics. With 3 state of the art research laboratories and 2 manufacturing units, Pharmathen is a completely vertically integrated company and its activities extend from the development of pharmaceutical products up to their distribution. The company's human resources works in the sectors of Research & Development (R&D), production and distribution of drugs to different countries worldwide. Now, Pharmathen's products are approved in all EU markets and distribution rights have been granted to the largest pharmaceutical companies in the world, particularly in Europe, the United States of America and Canada.

Pharmathen was founded in 1969 in Athens, as a private pharmaceutical company, and is focused on the development and marketing of pharmaceuticals, with a strong position in generics. With 3 state of the art research laboratories and 2 manufacturing units, Pharmathen is a completely vertically integrated company and its activities extend from the development of pharmaceutical products up to their distribution. The company's human resources works in the sectors of Research & Development (R&D), production and distribution of drugs to different countries worldwide. Now, Pharmathen's products are approved in all EU markets and distribution rights have been granted to the largest pharmaceutical companies in the world, particularly in Europe, the United States of America and Canada.

Algae Farms SA engages in the production of renewable and conventional biofuels. Its products include algae pellets and briquettes, and bio-algae. The company was founded by Panagiotis Panagiotopoulos in February 20, 2014 and is headquartered in Preveza, Greece.

Pharmathen SA develops, manufactures, and markets pharmaceuticals. Its products include a-cnotren, adicanil, alcinin, atostana, aurid, azapin, belifax, calci-10, deprevix cr, esmocard, farbovil, faxiven, depilonine pro, depilonine cream, aripiprazole, atorvastatin, brinzolamide, caspofungin, and clopidogrel. The company was founded in 1969 and is headquartered in Pallini, Greece.

Algae Farms SA engages in the production of renewable and conventional biofuels. Its products include algae pellets and briquettes, and bio-algae. The company was founded by Panagiotis Panagiotopoulos in February 20, 2014 and is headquartered in Preveza, Greece.

Algae Farms SA engages in the production of renewable and conventional biofuels. Its products include algae pellets and briquettes, and bio-algae. The company was founded by Panagiotis Panagiotopoulos in February 20, 2014 and is headquartered in Preveza, Greece.

Pharmathen Holding 2 Ltd. is an investment holding British company founded in 2015. The private company is based in St. Helier, UK. The company's main function is to hold investments.

Pharmathen SA develops, manufactures, and markets pharmaceuticals. Its products include a-cnotren, adicanil, alcinin, atostana, aurid, azapin, belifax, calci-10, deprevix cr, esmocard, farbovil, faxiven, depilonine pro, depilonine cream, aripiprazole, atorvastatin, brinzolamide, caspofungin, and clopidogrel. The company was founded in 1969 and is headquartered in Pallini, Greece.

Algae Farms SA engages in the production of renewable and conventional biofuels. Its products include algae pellets and briquettes, and bio-algae. The company was founded by Panagiotis Panagiotopoulos in February 20, 2014 and is headquartered in Preveza, Greece.

Pharmathen Holding 4 Ltd. is a holding British company that operates through its subsidiaries in the pharmaceutical industry. The private company is involved in the development and marketing of pharmaceutical products.

Pharmathen SA develops, manufactures, and markets pharmaceuticals. Its products include a-cnotren, adicanil, alcinin, atostana, aurid, azapin, belifax, calci-10, deprevix cr, esmocard, farbovil, faxiven, depilonine pro, depilonine cream, aripiprazole, atorvastatin, brinzolamide, caspofungin, and clopidogrel. The company was founded in 1969 and is headquartered in Pallini, Greece.

Pharmathen Pharmaceuticals SA develops and markets health care products. It manufactures cosmetics and pharmaceutical products and licenses out to the pharmaceutical companies in Europe, Canada, Australia, South Africa and the United States. The firm also distributes products in Africa, Asia, Latin America and the Middle East through a network of agents and distributors. The company was founded by Nicolas Katsos in 1969 and is headquartered in Pallini, Greece.

Pharmathen Pharmaceuticals SA develops and markets health care products. It manufactures cosmetics and pharmaceutical products and licenses out to the pharmaceutical companies in Europe, Canada, Australia, South Africa and the United States. The firm also distributes products in Africa, Asia, Latin America and the Middle East through a network of agents and distributors. The company was founded by Nicolas Katsos in 1969 and is headquartered in Pallini, Greece.

Pharmathen Pharmaceuticals SA develops and markets health care products. It manufactures cosmetics and pharmaceutical products and licenses out to the pharmaceutical companies in Europe, Canada, Australia, South Africa and the United States. The firm also distributes products in Africa, Asia, Latin America and the Middle East through a network of agents and distributors. The company was founded by Nicolas Katsos in 1969 and is headquartered in Pallini, Greece.

Pharmathen Pharmaceuticals SA develops and markets health care products. It manufactures cosmetics and pharmaceutical products and licenses out to the pharmaceutical companies in Europe, Canada, Australia, South Africa and the United States. The firm also distributes products in Africa, Asia, Latin America and the Middle East through a network of agents and distributors. The company was founded by Nicolas Katsos in 1969 and is headquartered in Pallini, Greece.

Pharmathen Pharmaceuticals SA develops and markets health care products. It manufactures cosmetics and pharmaceutical products and licenses out to the pharmaceutical companies in Europe, Canada, Australia, South Africa and the United States. The firm also distributes products in Africa, Asia, Latin America and the Middle East through a network of agents and distributors. The company was founded by Nicolas Katsos in 1969 and is headquartered in Pallini, Greece.

Pharmathen SA develops, manufactures, and markets pharmaceuticals. Its products include a-cnotren, adicanil, alcinin, atostana, aurid, azapin, belifax, calci-10, deprevix cr, esmocard, farbovil, faxiven, depilonine pro, depilonine cream, aripiprazole, atorvastatin, brinzolamide, caspofungin, and clopidogrel. The company was founded in 1969 and is headquartered in Pallini, Greece.